期刊
FASEB JOURNAL
卷 31, 期 12, 页码 5409-5418出版社
WILEY
DOI: 10.1096/fj.201700431R
关键词
insulin resistance; beta cells; tau; neurodegeneration; hyperglycemia
资金
- Canadian Institute of Health Research (CIHR) [MOP-115056]
- West Australian Department of Health Award
- National Health and Medical Research Council [APP1105698]
- CIHR
- Diabetes Canada
Alzheimer's disease (AD) and type 2 diabetes (T2D) present a significant risk to each other. AD and T2D are characterized by deposition of cerebral amyloid-beta (A beta) and pancreatic human islet amyloid polypeptide (hIAPP), respectively. We investigated the role of amyloidogenic proteins in the interplay between these diseases. A novel double transgenic mouse model combining T2D and AD was generated and characterized. AD-related amyloid transgenic mice coexpressing hIAPP displayed peripheral insulin resistance, hyperglycemia, and glucose intolerance. A beta and IAPP amyloidco-deposition increased tau phosphorylation, and a reduction in pancreatic beta-cell mass was detected inislets. Increased brain A beta deposition and tau phosphorylation and reduced insulin levels and signaling were accompanied by extensive synaptic loss and decreased neuronal counts. Ab immunization rescued the peripheral insulin resistance and hyperglycemia, suggesting a role for A beta in T2D pathogenesis for individuals predisposed to AD. These findings demonstrate that Ab and IAPP are key factors in the overlapping pathologies of AD and T2D.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据